Characterization of anticapsular monoclonal antibodies that regulate activation of the complement system by the Cryptococcus neoformans capsule

Characterization of anticapsular monoclonal antibodies that regulate activation of the complement system by the Cryptococcus neoformans capsule

Item
http://www.wikidata.org/entity/Q33752366
Monoclonal antibodies against peptidorhamnomannans of Scedosporium apiospermum enhance the pathogenicity of the fungusOpsonic requirements for dendritic cell-mediated responses to Cryptococcus neoformans.Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.Bivalency is required for anticapsular monoclonal antibodies to optimally suppress activation of the alternative complement pathway by the Cryptococcus neoformans capsule.Amphotericin B and fluconazole affect cellular charge, macrophage phagocytosis, and cellular morphology of Cryptococcus neoformans at subinhibitory concentrationsMolecular and idiotypic analyses of the antibody response to Cryptococcus neoformans glucuronoxylomannan-protein conjugate vaccine in autoimmune and nonautoimmune miceAntibody interactions with the capsule of Cryptococcus neoformansCapsular reactions of Cryptococcus neoformans with polyspecific and oligospecific polyclonal anticapsular antibodiesFc-dependent and Fc-independent opsonization of Cryptococcus neoformans by anticapsular monoclonal antibodies: importance of epitope specificityOf mice and men, revisited: new insights into an ancient molecule from studies of complement activation by Cryptococcus neoformansContribution of epitope specificity to the binding of monoclonal antibodies to the capsule of Cryptococcus neoformans and the soluble form of its major polysaccharide, glucuronoxylomannan.Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection.Monoclonal antibodies reactive with immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformansCharacteristics of Fc-independent human antimannan antibody-mediated alternative pathway initiation of C3 deposition to Candida albicans.The capsule of the fungal pathogen Cryptococcus neoformans.An opsonizing monoclonal antibody that recognizes a noncapsular epitope expressed on Cryptococcus neoformans.Specific antibody can prevent fungal biofilm formation and this effect correlates with protective efficacy.
P2860

Characterization of anticapsular monoclonal antibodies that regulate activation of the complement system by the Cryptococcus neoformans capsule

Item
http://www.wikidata.org/entity/Q33752366
description
1998 nî lūn-bûn
@nan
1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Characterization of anticapsul ...... ryptococcus neoformans capsule
@ast
Characterization of anticapsul ...... ryptococcus neoformans capsule
@en
type
label
Characterization of anticapsul ...... ryptococcus neoformans capsule
@ast
Characterization of anticapsul ...... ryptococcus neoformans capsule
@en
prefLabel
Characterization of anticapsul ...... ryptococcus neoformans capsule
@ast
Characterization of anticapsul ...... ryptococcus neoformans capsule
@en
P1433
P1476
P2093
P2860
P304
P31
P407
P433
P478
P50
P577
P698
P932
P1433
P1476
Characterization of anticapsul ...... ryptococcus neoformans capsule
@en
P2093
P2860
P304
P31
P407
P433
P478
P50
P577
P698
P932